Generative AI for weakly supervised segmentation and downstream classification of brain tumors on MR images.

Journal: Scientific reports
Published Date:

Abstract

Segmenting abnormalities is a leading problem in medical imaging. Using machine learning for segmentation generally requires manually annotated segmentations, demanding extensive time and resources from radiologists. We propose a weakly supervised approach that utilizes binary image-level labels, which are much simpler to acquire, rather than manual annotations to segment brain tumors on magnetic resonance images. The proposed method generates healthy variants of cancerous images for use as priors when training the segmentation model. However, using weakly supervised segmentations for downstream tasks such as classification can be challenging due to occasional unreliable segmentations. To address this, we propose using the generated non-cancerous variants to identify the most effective segmentations without requiring ground truths. Our proposed method generates segmentations that achieve Dice coefficients of 79.27% on the Multimodal Brain Tumor Segmentation (BraTS) 2020 dataset and 73.58% on an internal dataset of pediatric low-grade glioma (pLGG), which increase to 88.69% and 80.29%, respectively, when removing suboptimal segmentations identified using the proposed method. Using the segmentations for tumor classification results with Area Under the Characteristic Operating Curve (AUC) of 93.54% and 83.74% on the BraTS and pLGG datasets, respectively. These are comparable to using manual annotations which achieve AUCs of 95.80% and 83.03% on the BraTS and pLGG datasets, respectively.

Authors

  • Jay J Yoo
    University of Toronto, Institute of Medical Science, Toronto, M5S 1A8, Canada.
  • Khashayar Namdar
    Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
  • Matthias W Wagner
    Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
  • Kristen W Yeom
    Department of Radiology, Stanford University, Stanford, California, United States of America.
  • Liana F Nobre
    Division of Hematology/Oncology (iHOPE), Department of Pediatrics, University of Alberta, Edmonton, T6G 1C9, Canada.
  • Uri Tabori
    Institute of Medical Science (M.D.S., K.N., U.T., F.K., B.B.E.-W.), University of Toronto, Toronto, Ontario, Canada.
  • Cynthia Hawkins
    The Arthur and Sonia Labatt Brain Tumour Research Centre (U.T., C.H.), The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Birgit B Ertl-Wagner
    From the Department of Radiology, University of Wisconsin Madison School of Medicine and Public Health, 600 Highland Dr, Madison, WI 53792 (D.A.B., M.L.S.); Department of Radiology, New York University, New York, NY (L.M.); Department of Musculoskeletal Radiology (M.A.B.) and Institute for Technology Assessment (E.F.H.), Massachusetts General Hospital, Boston, Mass; Department of Medical Imaging, Hospital for Sick Children, University of Toronto, Toronto, Canada (B.B.E.W.); Department of Radiology, University of California-San Diego, San Diego, Calif (K.J.F.); Department of Cancer Imaging, Division of Imaging Sciences & Biomedical Engineering, Kings College London, London, England (V.J.G.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (C.P.H.); and Department of Radiology and Radiologic Science, The Johns Hopkins University School of Medicine, Baltimore, Md (C.R.W.).
  • Farzad Khalvati
    Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada. farzad.khalvati@utoronto.ca.